Abbreviation for a chemotherapy regimen of Adriamycin (doxorubicin), bleomycin, vinblastine, and dacarbazine; used in the treatment of Hodgkin lymphoma.
As scientists who evolve with technology we treat innovation as a way of life, a life we dedicate to improvement and advancement of Safety, Health and Environment.